Depressive-anxious disorders in clinical picture of bronchial asthma combined with erosive-ulcerous affections of gastroduodenal zone

QR Code

Depressive-anxious disorders in clinical picture of bronchial asthma combined with erosive-ulcerous affections of gastroduodenal zone

In the paper a popularity frequency and peculiarities of depressive-troubled disorder (DAD) course at patients with bronchial asthma (BA) have been estimated depending on the presence of associated erosive-ulcerous affections of gastroduodenal zone (EUA GDZ) and an impact of DAD on BA course has bee...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Ye. A. Ustjuzhanina, G. M. Chernyavskaya, E. I. Beloborodova, N. A. Kornetov
Hōputu:	Tuhinga
Reo:	Ingarihi
I whakaputaina:	Siberian State Medical University (Tomsk) 2004-12-01
Rangatū:	Бюллетень сибирской медицины
Ngā marau:	bronchial asthma erosive-ulcerous affections of gastroduodenal zone depressive-anxious disorders
Urunga tuihono:	https://bulletin.ssmu.ru/jour/article/view/3730
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

Clinic immunological comparison when studying erosive affections of gastro duodenal zone in patients with bronchial asthma
mā: G. M. Chernyavskaya, me ētahi atu.
I whakaputaina: (2003-03-01)

Anxiety-depressive disorders in patients with bronchial asthma combined with erosive-ulcerative lesions of gastro-duodenal area
mā: E. I. Beloborodova, me ētahi atu.
I whakaputaina: (2007-03-01)

REVISITING CAUSES AND FEATURES OF TREATMENT FOR EROSIVE AND ULCERATIVE GASTRODUODENAL BLEEDING IN PATIENTS WITH ACUTE CARDIAC DISEASES (REVIEW OF LITERATURE)
mā: L. F. Tveritneva
I whakaputaina: (2016-03-01)

NazvanCapabilities of non-atrofic antral helicobacter-associated gastritis diagnostics at the patients suffering from a duodenal ulcer combnined with bronchial asthma when examining Gastropanel test system
mā: G. V. Maksimenko, me ētahi atu.
I whakaputaina: (2012-02-01)

Airway hyperresponsiveness in bronchial asthma: pathogenesis basics
mā: I. A. Deyev, me ētahi atu.
I whakaputaina: (2002-12-01)

Clinical and endoscopic peculiarities of gastroesophageal reflux disease during bronchial asthma combined with chronic opisthorchosis
mā: G. M. Chernyavskaya, me ētahi atu.
I whakaputaina: (2003-12-01)

CLINICAL-IMMUNOLOGICAL EFFECTIVENESS OF RIBOMUNYL IN CHILDREN WITH VIRUS-INDUCED BRONCHIAL ASTHMA
mā: E. B. Belan, me ētahi atu.
I whakaputaina: (2020-12-01)

FEATURES OF TRANSFORMATIONS OF RED BLOOD CELLS IN CHILDREN WITH BRONCHIAL ASTHMA
mā: E. N. Suprun, me ētahi atu.
I whakaputaina: (2017-12-01)

Quality of life in patients having severe bronchial asthma
mā: T. V. Smetanenko, me ētahi atu.
I whakaputaina: (2005-12-01)

Epithelial barrier dysfunction in bronchial asthma
mā: R. N. Khramova, me ētahi atu.
I whakaputaina: (2022-09-01)

Modern Understanding of Severe Bronchial Asthma
mā: A. Yu. Kraposhina, me ētahi atu.
I whakaputaina: (2022-03-01)

Problem of comorbidity in patients with bronchial asthma
mā: D. V. Ushakova, me ētahi atu.
I whakaputaina: (2021-06-01)

Evaluation of serum Vitamin D3 level and its association with the severity of asthma and asthma control among the adult Indian population with bronchial asthma: A cross-sectional study
mā: Dhwani Patel, me ētahi atu.
I whakaputaina: (2025-01-01)

PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE
mā: N. V. Ivanova, me ētahi atu.
I whakaputaina: (2015-12-01)

Cytokines and nitric oxide in case of bronchial asthma
mā: F. I. Petrovsky, me ētahi atu.
I whakaputaina: (2002-03-01)

OPTIMIZATION OF SURGICAL TACTICS ULCEROUS GASTRODUODENAL BLEEDING
mā: G. K. KARIPIDI, me ētahi atu.
I whakaputaina: (2017-06-01)

SOME FUNCTIONAL FEATURES OF COURSE OF BRONCHIAL ASTHMA COMBINED WITH ESSENTIAL HYPERTENSION
mā: O. M. Uryasev, me ētahi atu.
I whakaputaina: (2015-09-01)

Diagnostic capabilities of external respiration function methods in children with bronchial asthma
mā: A. A. Lebedenko, me ētahi atu.
I whakaputaina: (2017-06-01)

Morpho-functional aspects of mutual influence of bronchial asthma and gastroesophageal reflux
mā: R. I. Pleshko, me ētahi atu.
I whakaputaina: (2005-12-01)

FEATURES OF DYNAMICS OF MOTOR AND ANXIOUS-DEPRESSED DISORDERS ARE IN THE PERIOD OF REHABILITATION OF STROKE
mā: V. A. Chistyakova, me ētahi atu.
I whakaputaina: (2016-03-01)

Bronchial asthma in the era of personalized medicine
mā: A. Kh. Ibisheva, me ētahi atu.
I whakaputaina: (2025-01-01)

Targeted therapy of bronchial asthma in children
mā: R. M. Fayzullina, me ētahi atu.
I whakaputaina: (2022-07-01)

Risk factors for bronchial asthma in children in Chita Region
mā: I. N. Gaimolenko, me ētahi atu.
I whakaputaina: (2007-12-01)

The role of periostin as an inflammatory marker in bronchial asthma in children
mā: N. A. Belykh, me ētahi atu.
I whakaputaina: (2024-10-01)

Bronchial Asthma in Youth: A Brief Concept Review
mā: Roberto W. Dal Negro
I whakaputaina: (2025-06-01)

SOME FEATURES OF CHANGING TELOMERE LENGTH IN LYMPHOCYTES FROM THE PATIENTS WITH BRONCHIAL ASTHMA
mā: V. I. Borisov, me ētahi atu.
I whakaputaina: (2014-07-01)

IMMUNE STATE OF THE CHILDREN WITH BRONCHIAL ASTHMA FROM THE AMUR RIVER AND YAKUTIA REGIONS
mā: M. V. Efimenko, me ētahi atu.
I whakaputaina: (2014-07-01)

Phenotypic features of a patient with bronchial asthma in the clinical practice of a pediatrician
mā: R. N. Khokha, me ētahi atu.
I whakaputaina: (2023-07-01)

Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
mā: A. F. Ivanov, me ētahi atu.
I whakaputaina: (2018-04-01)

Safety and efficiency of using Omaulizumab in bronchial asthma
mā: E. A. Strel’tsov, me ētahi atu.
I whakaputaina: (2019-09-01)

The role of macroelements in the pathogenesis of bronchial asthma in children
mā: A. A. Lebedenko, me ētahi atu.
I whakaputaina: (2021-07-01)

IMMUNOLOGICAL MARKERS OF UNCONTROLLED ATOPIC BRONCHIAL ASTHMA IN CHILDREN
mā: M. V. Smolnikova, me ētahi atu.
I whakaputaina: (2017-08-01)

Bronchial Asthma among Chechen Republic Schoolchildren: Regional Features
mā: Aset Kh. Ibisheva, me ētahi atu.
I whakaputaina: (2024-11-01)

PATHOGENETIC JUSTIFICATION AND EFFICIENCY OF MELATONIN APPLICATION IN PATIENTS WITH BRONCHIAL ASTHMA
mā: G. I. Litvinenko, me ētahi atu.
I whakaputaina: (2014-07-01)

THYMOPOIESIS INTENSITY IN PATIENTS WITH BRONCHIAL ASTHMA, DEPENDING ON DURATION OF THE DISEASE
mā: E. A. Blinova, me ētahi atu.
I whakaputaina: (2014-07-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
mā: V. A. Nikitin, me ētahi atu.
I whakaputaina: (2016-03-01)

Epidemiological trends of bronchial asthma symptoms in adolescent children in the Udmurt Republic. The results of long-term research
mā: L. P. Matveeva, me ētahi atu.
I whakaputaina: (2025-06-01)

The role of cathepsin S in the pathophysiology of bronchial asthma
mā: A. Yu. Kraposhina, me ētahi atu.
I whakaputaina: (2022-10-01)

RATIONALE FOR A SPECIFIC THERAPY OF CYTOMEGALOVIRUS INFECTION IN CHILDREN WITH BRONCHIAL ASTHMA
mā: E. N. Suprun, me ētahi atu.
I whakaputaina: (2014-07-01)

The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity
mā: O. Yu. Kytikova, me ētahi atu.
I whakaputaina: (2021-04-01)